This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Startup Springboard in partnership with BIO-Europe Spring®
March 18, 2021
Delivered DigitallyCentral European Time

TRIO Pharmaceuticals, Inc.

Profile

Developing dual action antibody drug conjugates (ADC) to stop both tumor growth and immunosuppression. In the IO treatment landscape our dual action ADCs will increase efficacy by generating a more immunogenic tumor. We demonstrated our technology in cell and animal models.